Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia

被引：48
|
作者：
Ulhaq, Zulvikar Syambani [1 ]
Soraya, Gita Vita [2 ]
机构：
[1] Maulana Malik Ibrahim Islamic State Univ Malang, Dept Biochem, Fac Med & Hlth Sci, Batu 65151, East Java, Indonesia
[2] Hasanuddin Univ, Dept Biochem, Fac Med, Makassar 90245, South Sulawesi, Indonesia
来源：
MEDICINA CLINICA | 2020年 / 155卷 / 12期
关键词：
OFF-LABEL USE; TOCILIZUMAB; INTERLEUKIN-6;
D O I：
10.1016/j.medcli.2020.07.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：548 / 556
页数：9
相关论文
共 50 条
  • [41] The IL-6 Inhibitor Tocilizumab in COVID-19
    Meinrenken, Susanne
    PNEUMOLOGIE, 2021, 75 (05):
  • [42] Alleviation of systemic manifestations of Castleman's disease by blockade of IL-6 signal transduction with humanized anti-IL-6 receptor antibody.
    Nishimoto, N
    Sasai, M
    Shima, Y
    Danno, N
    Yoshizaki, K
    Kishimoto, T
    BLOOD, 1996, 88 (10) : 1243 - 1243
  • [43] Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Rejection - Molecular Rebound Phenomena Under IL-6 Blockade?
    Borski, A.
    Haindl, S.
    Duerr, M.
    Budde, K.
    Schranz, S.
    Eskandary, F. A.
    Doberer, K.
    Halloran, P. F.
    Chong, E.
    Jilma, B.
    Boehmig, G. A.
    Wahrmann, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 853 - 853
  • [44] Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population
    Rodrigues, Fabiola Brasil Barbosa
    da Silva, Rosilene
    dos Santos, Erika Ferreira
    de Brito, Mioni Thieli Figueiredo Magalhaes
    da Silva, Andrea Luciana Soares
    Leite, Mauro de Meira
    da Costa, Flavia Povoa
    Viana, Maria de Nazare do Socorro de Almeida
    de Sarges, Kevin Matheus Lima
    Cantanhede, Marcos Henrique Damasceno
    Verissimo, Adriana de Oliveira Lameira
    Carvalho, Mayara da Silva
    Henriques, Daniele Freitas
    da Silva, Carla Pinheiro
    Costa, Igor Brasil
    Nunes, Juliana Abreu Lima
    Costa, Iran Barros
    Viana, Giselle Maria Rachid
    Queiroz, Maria Alice Freitas
    Lima, Sandra Souza
    Lopes, Jeferson da Costa
    Torres, Maria Karoliny da Silva
    Vallinoto, Izaura Maria Vieira Cayres
    Bichara, Carlos David Araujo
    Vallinoto, Antonio Carlos Rosario
    dos Santos, Eduardo Jose Melo
    VIRUSES-BASEL, 2023, 15 (05):
  • [45] INCREASED CIRCULATING INTERLEUKIN-6 (IL-6) ACTIVITY IN ENDOTOXIN-CHALLENGED MICE PRETREATED WITH ANTI-IL-6 ANTIBODY IS DUE TO IL-6 ACCUMULATED IN ANTIGEN-ANTIBODY COMPLEXES
    MARTENS, E
    DILLEN, C
    PUT, W
    HEREMANS, H
    VANDAMME, J
    BILLIAU, A
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (08) : 2026 - 2029
  • [46] Implication of IL-12A, IL-12B, IL-6, and TNF single-nucleotide polymorphisms in severity and susceptibility to COVID-19
    Benmansour, R.
    Tagajdid, M. R.
    Lahlou, I. A.
    Oumzil, H.
    El Hamzaoui, H.
    Fjouji, S.
    Doghmi, N.
    Houba, A.
    Elkochri, S.
    Aabi, R.
    Elannaz, H.
    Laraqui, A.
    El Mchichi, B.
    Touil, N.
    Ennibi, K.
    Bouhouche, A.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2024, 38
  • [47] The role of IL-6 receptor inhibitor treatment in critical patient monitoring with COVID-19
    Ciyiltepe, Fulya
    Saracoglu, Ayten
    Bilir, Yeliz
    Deniz, Elif Akova
    Bombaci, Elif
    Saracoglu, Kemal Tolga
    SIGNA VITAE, 2021, 17 (03) : 174 - 180
  • [48] ANTI-IL-6 ANTIBODY CLAZAKIZUMAB IN LATE ANTIBODY-MEDIATED REJECTION - MOLECULAR REBOUND PHENOMENA UNDER IL-6 BLOCKADE?
    Borski, Anita
    Haindl, Susanne
    Durr, Michael
    Budde, Klemens
    Schranz, Sabine
    Eskandary, Farsad A.
    Doberer, Konstantin
    Halloran, Philip F.
    Chong, Edward
    Jilma, Bernd
    Bohmig, Georg A.
    Wahrmann, Markus
    TRANSPLANTATION, 2020, 104 (09) : S67 - S67
  • [49] Genetic IL-6R variants and therapeutic inhibition of IL-6 receptor signalling in COVID-19
    Garbers, Christoph
    Rose-John, Stefan
    LANCET RHEUMATOLOGY, 2021, 3 (02): : E96 - E97
  • [50] Molecular mechanism of Anti-IL-6 receptor antibody treatment in collagen-induced arthritis
    Fuiimoto, Minoru
    Serada, Satoshi
    Matsukawa, Yuko
    Nakano, Mayumi
    Nishikawa, Teppei
    Kishimoto, Tadamitsu
    Naka, Tetsuji
    CYTOKINE, 2007, 39 (01) : 11 - 11
12345